M174-2

Sputum: Methicillin resistant Staphylococcus aureus (MRSA) – Shipped February 13, 2018 – 

HISTORY

All simulated sputum collected from 54 year old male in ICU was sent to category A and B laboratories.
Participants were expected to identify methicillin resistant Staphylococcus aureus (MRSA), and report susceptibilities. Laboratories were also expected to report the isolate to Infection Control (IC).

MAIN EDUCATIONAL POINTS from M174-2

  1. MRSA pneumonia is associated with high morbidity and mortality
  2. Compliance with institutional Infection Control recommendations help mitigate against the spread of MRSA in healthcare settings

Full critique (PDF)

Posted in Clinical Bacteriology Results, critiques